Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
McCarthy
James
J
D015766:Albendazole / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology* / Q000627:therapeutic use; D004049:Diethylcarbamazine / Q000494:pharmacology* / Q000627:therapeutic use; D004351:Drug Resistance / Q000235:genetics; D004359:Drug Therapy, Combination; D004605:Elephantiasis, Filarial / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007559:Ivermectin / Q000494:pharmacology* / Q000627:therapeutic use; D014404:Tubulin / Q000235:genetics; D014958:Wuchereria bancrofti / Q000187:drug effects* / Q000235:genetics
D000871:Anthelmintics; D014404:Tubulin; D007559:Ivermectin; D015766:Albendazole; D004049:Diethylcarbamazine